Terms: = Liver cancer AND FES, FPS, 2242, ENSG00000182511, P07332
49 results:
1. [Evaluation of the Short-Term Efficacy and Safety of Orelabrutinib Combined with High-Dose Methotrexate in the First-line Treatment of Elderly Patients with High Risk Primary Central Nervous System Lymphoma].
Xie Y; Qu S; Liao LS; Zheng ZH; Lin Y; Chen WM; Chen BY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1714-1719. PubMed ID: 38071050
[TBL] [Abstract] [Full Text] [Related]
2. The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline.
Meng Z; Li P; Yang D; Huang H; Dong H; Qin Y; Bin Y; Li R; Wang S; Chen X; Kang M
Radiother Oncol; 2024 Feb; 191():110027. PubMed ID: 38008418
[TBL] [Abstract] [Full Text] [Related]
3. Survival analysis over a 20-year period of a Brazilian cohort of blood donors coinfected HIV-HCV.
de Menezes Filho HR; Grandi G; Vaz Cardoso LP; Galvão da Silva JF; Machado SM; de Almeida-Neto C; Sabino EC; Mendes-Corrêa MC
Braz J Infect Dis; 2023; 27(5):102810. PubMed ID: 37813358
[TBL] [Abstract] [Full Text] [Related]
4. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
[TBL] [Abstract] [Full Text] [Related]
5. Dense-PSP-UNet: A neural network for fast inference liver ultrasound segmentation.
Ansari MY; Yang Y; Meher PK; Dakua SP
Comput Biol Med; 2023 Feb; 153():106478. PubMed ID: 36603437
[TBL] [Abstract] [Full Text] [Related]
6. Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma.
Li D; Shi Z; Liu X; Jin S; Chen P; Zhang Y; Chen G; Fan X; Yang J; Lin H
Hepatol Int; 2023 Feb; 17(1):112-130. PubMed ID: 36598701
[TBL] [Abstract] [Full Text] [Related]
7. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
8. High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.
Giangregorio F; Garolfi M; Mosconi E; Ricevuti L; Debellis MG; Mendozza M; Esposito C; Vigotti E; Cadei D; Abruzzese D
J Ultrasound; 2023 Mar; 26(1):71-79. PubMed ID: 36227456
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of tumour heterogeneity by
Liu C; Hu S; Xu X; Zhang Y; Wang B; Song S; Yang Z
Breast Cancer Res; 2022 Aug; 24(1):57. PubMed ID: 36028895
[TBL] [Abstract] [Full Text] [Related]
10. liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
Kugelmas M; Zapata I; Tawil J; Pessetto A; Taglienti M; Kugelmas M
Dig Dis Sci; 2023 Mar; 68(3):931-938. PubMed ID: 35670896
[TBL] [Abstract] [Full Text] [Related]
11. 16α-18F-fluoro-17β-Fluoroestradiol (fes): Clinical Applications for Patients With Breast cancer.
Ulaner GA
Semin Nucl Med; 2022 Sep; 52(5):574-583. PubMed ID: 35379454
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Signature Predictive of Long-Term liver Fibrosis Progression to Inform Antifibrotic Drug Development.
Qian T; Fujiwara N; Koneru B; Ono A; Kubota N; Jajoriya AK; Tung MG; Crouchet E; Song WM; Marquez CA; Panda G; Hoshida A; Raman I; Li QZ; Lewis C; Yopp A; Rich NE; Singal AG; Nakagawa S; Goossens N; Higashi T; Koh AP; Bian CB; Hoshida H; Tabrizian P; Gunasekaran G; Florman S; Schwarz ME; Hiotis SP; Nakahara T; Aikata H; Murakami E; Beppu T; Baba H; Rew Warren ; Bhatia S; Kobayashi M; Kumada H; Fobar AJ; Parikh ND; Marrero JA; Rwema SH; Nair V; Patel M; Kim-Schulze S; Corey K; O'Leary JG; Klintmalm GB; Thomas DL; Dibas M; Rodriguez G; Zhang B; Friedman SL; Baumert TF; Fuchs BC; Chayama K; Zhu S; Chung RT; Hoshida Y
Gastroenterology; 2022 Apr; 162(4):1210-1225. PubMed ID: 34951993
[TBL] [Abstract] [Full Text] [Related]
13. Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.
Zager RA; Johnson ACM; Therapeutics R
Nephrol Dial Transplant; 2021 Feb; 36(3):465-474. PubMed ID: 33547792
[TBL] [Abstract] [Full Text] [Related]
14. Head-to-Head Evaluation of
Ulaner GA; Jhaveri K; Chandarlapaty S; Hatzoglou V; Riedl CC; Lewis JS; Mauguen A
J Nucl Med; 2021 Mar; 62(3):326-331. PubMed ID: 32680923
[TBL] [Abstract] [Full Text] [Related]
15. Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study.
Feng J; He Y; Wan J; Chen Z
HPB (Oxford); 2020 Sep; 22(9):1295-1304. PubMed ID: 31892468
[TBL] [Abstract] [Full Text] [Related]
16. Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.
Boers J; Venema CM; de Vries EFJ; Glaudemans AWJM; Kwee TC; Schuuring E; Martens JWM; Elias SG; Hospers GAP; Schröder CP
Eur J Cancer; 2020 Feb; 126():11-20. PubMed ID: 31891878
[TBL] [Abstract] [Full Text] [Related]
17. Molecular mechanisms of oxidation damage and liver cell dysfunction in patients with metastatic colorectal cancer.
Burlaka AP; Burlaka AA; Virko SV; Ganusevich II
Exp Oncol; 2019 Dec; 41(4):328-334. PubMed ID: 31868333
[TBL] [Abstract] [Full Text] [Related]
18. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical value of (125)I radioactive seed implantation plus transcatheter arterial chemoembolization combined with radiofrequency ablation in treating patient with sub-capsular hepatocellular carcinoma].
Fang SJ; Gao RJ; Zheng LY; Zhao ZW; Fan XX; Song JJ; Zhang DK; Wu FZ; Ji JS
Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3853-3857. PubMed ID: 30585029
[No Abstract] [Full Text] [Related]
20.
Nienhuis HH; van Kruchten M; Elias SG; Glaudemans AWJM; de Vries EFJ; Bongaerts AHH; Schröder CP; de Vries EGE; Hospers GAP
J Nucl Med; 2018 Aug; 59(8):1212-1218. PubMed ID: 29602822
[TBL] [Abstract] [Full Text] [Related]
[Next]
